391 results on '"Saji, Tsutomu"'
Search Results
2. Treatment Options for Refractory Kawasaki Disease: Alternative Treatments for Infliximab Nonresponders
3. Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan
4. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan
5. Pulmonary Arterial Capacitance Index Is a Strong Predictor for Adverse Outcome in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension
6. Sildenafil reduces pulmonary vascular resistance in single ventricular physiology
7. Kawasaki’s Disease
8. Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression
9. Unexpected pulmonary hypertensive crisis after surgery for ocular malignant melanoma
10. Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome
11. Low risk of treatment resistance in Down syndrome with Kawasaki disease
12. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
13. Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension
14. Outcomes of Childhood Pulmonary Arterial Hypertension in BMPR2 and ALK1 Mutation Carriers
15. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
16. Guideline for Catheter Intervention in Coronary Artery Lesion in Kawasaki Disease
17. Treatment Options for Refractory Kawasaki Disease: Alternative Treatments for Infliximab Nonresponders
18. Pharmacokinetics of Bosentan in Routinely Treated Japanese Pediatric Patients with Pulmonary Arterial Hypertension
19. Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan
20. Lack of Human Herpesvirus 8 Infection in Lungs of Japanese Patients with Primary Pulmonary Hypertension
21. Kawasaki disease: basic and pathological findings
22. Transcatheter atrial septal defect closure in a patient with paradoxical brain emboli: who should treat it and who should be treated?
23. Bidirectional Glenn procedure for an infected modified Blalock–Taussig shunt
24. Serum adipokine profiles in Kawasaki disease
25. Fontan conversion with novel direct ablation after childbirth: Report of a case
26. Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome
27. National Japanese survey of thrombolytic therapy selection for coronary aneurysm: Intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease
28. Kawasaki’s Disease
29. PREEMPTIVE THERAPY TO CYTOMEGAROVIRUS INFECTION IN CHILDREN AFTER KIDNEY TRANSPLANTATION.: Abstract# 48
30. Two hyperandrogenic adolescent girls with congenital portosystemic shunt
31. Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University
32. Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients
33. Mutation Analysis of BMPR2 and other Genes in Japanese Patients with Pediatric Primary Pulmonary Hypertension
34. Standard method for ultrasound imaging of coronary artery in children
35. Common variants in CASP3 confer susceptibility to Kawasaki disease
36. Ventricular septal defect repair in an infant with severe pulmonary hypertension and preoperatively diagnosed left ventricular noncompaction
37. Surgical treatment of total anomalous pulmonary venous connection —Clinical aspects of pulmonary venous obstruction—
38. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome
39. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG
40. Infliximab for Kawasaki syndrome
41. Guidelines for the use of palivizumab in infants and young children with congenital heart disease
42. Safety and efficacy of palivizumab prophylaxis in children with congenital heart disease
43. Tissue Doppler Imaging Predicts Adverse Outcome in Children with Idiopathic Pulmonary Arterial Hypertension
44. Evaluation of viral myocarditis in children by radionuclide method
45. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease
46. Gene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungs
47. Detection of Pediatric Pulmonary Arterial Hypertension by School Electrocardiography Mass Screening
48. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial
49. Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease
50. Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.